After completing this activity, pharmacists should be able to:
- Explain the pharmacology of naloxone and describe its role in preventing opioid overdose death;
- Identify patients who may benefit from take‑home naloxone;
- Explain to patients and their close contacts, how to recognise an opioid overdose and counsel for safe and effective use of take‑home naloxone;
- List the available take‑home naloxone formulations, and compare and contrast the different formulations.
The 2016 Competency Standards addressed by this activity include: 1.1, 1.5, 2.3, 3.1, 3.2, 3.5, 3.6.
Accreditation number: A1907AJP3 Accreditation expires: 01/07/2021
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.